Optical imaging developer VisEn Medical is introducing its NanoSparks line of optical imaging probes at this week’s annual conference of the Academy of Molecular Imaging (AMI) in Orlando, FL.
The probes include AminoSpark 680, a platform label that can be conjugated to a range of targeting molecules, according to the Woburn, MA-based firm. CellSpark 680 is a nanoparticle label used to track the location and movement of cells in vivo, VisEn said.
Designed for intravital microscopy applications, AngioSpark 680 is a nanoparticle probe designed for fluorescent imaging of vascularity and angiogenesis, VisEn said. The three NanoSparks probes are expected to begin shipping in the second quarter, with additional probes planned for later this year.
By AuntMinnie.com staff writers
March 28, 2006
Related Reading
Analogic to provide FMT systems to VisEn Medical, June 7, 2004
Siemens takes stake in VisEn Medical, August 7, 2003
Copyright © 2006 AuntMinnie.com
